Fluid and nutrient intake and risk of chronic kidney disease

Nephrology

Volumn 16, Issue 3, 2011, Pages 326-334

  Strippoli, Giovanni F M ^a,b,c   Craig, Jonathan C ^a,b   Rochtchina, Elena ^d   Flood, Victoria M ^d   Wang, Jie Jin ^d   Mitchell, Paul ^d  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b School of Public Health   (Italy)

^c Diaverum Italy Medical Office   (Italy)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

chronic kidney disease; epidemiology; fluid; nutrient; water

Indexed keywords

BETA CAROTENE; CALCIUM; CARBOHYDRATE; CREATININE; FOLIC ACID; MAGNESIUM; MONOUNSATURATED FATTY ACID; PHOSPHORUS; POLYUNSATURATED FATTY ACID; PROTEIN; RETINOL; RIBOFLAVIN; STARCH; SUGAR; THIAMINE; ZINC;

ADULT; AGED; ARTICLE; ASSOCIATION; AUSTRALIA; CALORIC INTAKE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; FLUID INTAKE; FOOD FREQUENCY QUESTIONNAIRE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DRINKING; EATING; ENERGY INTAKE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW SOUTH WALES; NUTRITION SURVEYS; NUTRITIONAL STATUS; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79951980978     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01415.x     Document Type: Article

References (41)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS,. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003; 41: 1-12. (Pubitemid 36043346)
2. Atkins RC,. The changing patterns of chronic kidney disease: The need to develop strategies for prevention relevant to different regions and countries. Kidney Int. 2005; 68: S83-5.
3. Best PJ, Reddan DN, Berger PB, Szczech LA, McCullough PA, Califf RM,. Cardiovascular disease and chronic kidney disease: Insights and an update. Am. Heart J. 2004; 148: 230-42. (Pubitemid 39092788)
4. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 1998; 32: 992-9. (Pubitemid 28551162)
5. Xue JL, Ma JZ, Louis TA, Collins AJ,. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J. Am. Soc. Nephrol. 2001; 12: 2753-8. (Pubitemid 33115423)
6. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Circulation 2003; 108: 2154-69. (Pubitemid 37337595)
7. Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Eurberg CD,. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J. Am. Coll. Cardiol. 2001; 38: 705-11. (Pubitemid 32835740)
8. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S,. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann. Intern. Med. 2001; 134: 629-36. (Pubitemid 32322240)
9. Nass CM, Reck K,. Clinical challenges: The intersection of diabetes, chronic kidney disease, and cardiovascular disease. Curr. Diab. Rep. 2004; 4: 1-2. (Pubitemid 39359504)
10. Chua DY, Bakris GL,. Diabetes and chronic kidney disease: Tragedy and challenge. Blood Purif. 2004; 22: 130-35. (Pubitemid 38142298)
11. Cases A,. New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: Homocysteine, reactive C protein. Fibrinogen. Nefrologia 2004; 24: 62-72.
12. Szromba C,. Smoking in chronic kidney disease. Nephrol. Nurs. J. 2003; 30: 578-89.
13. Wheeler DC,. Does lipid-lowering therapy slow progression of chronic kidney disease? Am. J. Kidney Dis. 2004; 44: 917-20. (Pubitemid 39445926)
14. Shoham DA, Vupputuri S, Kshirsagar AV,. Chronic kidney disease and life course socioeconomic status: A review. Adv. Chronic Kidney Dis. 2005; 12: 56-63. (Pubitemid 40255604)
15. Fathi R, Isbel N, Short L, Haluska B, Johnson D, Marwick TH,. The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease. Am. J. Kidney Dis. 2004; 43: 45-52. (Pubitemid 38049434)
16. Krane V, Wanner C,. The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease. Nephrol. Dial. Transplant. 2002; 17: 23-7. (Pubitemid 35277059)
17. Heintz R,. Kidney in the Hospital and in Out-Patient. Stutt-gart: Georg Thieme Verlag, 1964.
18. Stefanski A, Ritz E, Amann K,. Factors affecting progression of renal failure-Experimental data. In:, Kopple JD, Massry SG, (eds). Nutritional Management of Renal Disease. Baltimore: Williams & Wilkins, 1997; 277-316.
19. Wenzel UO, Hebert LA, Stahl RAK, Krenz I,. My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2006; 1: 344-6.
20. Mitchell P, Smith W, Attebo K, Wang JJ,. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450-60.
21. Cumming RG, Mitchell P, Leeder SR,. Use of inhaled corticosteroids and the risk of cataracts. N. Engl. J. Med. 1997; 337: 8-14. (Pubitemid 27290841)
22. Cugati S, Kifley A, Mitchell P, Wang JJ,. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings. Diabetes Res. Clin. Pract. 2006; 74: 301-8. (Pubitemid 44604313)
23. Foran S, Wang JJ, Mitchell P,. Causes of visual impairment in two older population cross-sections: The Blue Mountains Eye Study. Ophthalmic Epidemiol. 2003; 10: 215-25. (Pubitemid 37041277)
24. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am. J. Epidemiol. 1988; 127: 188-99. (Pubitemid 18034380)
25. Flood VM, Smith WT, Webb KL, Mitchell P,. Issues in assessing the validity of nutrient data obtained from a food-frequency questionnaire: Folate and vitamin B12 examples. Public Health Nutr. 2004; 7: 751-6. (Pubitemid 39159043)
26. Cockcroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
27. Department of Commonwealth Services and Health. NUTTAB90 and NUTTAB95 Nutrient Data Tables for Use in Australia. Canberra: Australian Government Publishing Services, 1990; 1995.
28. Willett WC, Stampfer MJ,. Total energy intake: Implications for epidemiologic analyses. Am. J. Epidiol. 1986; 124: 17-27. (Pubitemid 16095831)
29. Bouby N, Bachman S, Bichet D, Bankir L,. Effect of water intake on the progression of chronic renal failure in 5/6 nephrectomized rat. Am. J. Physiol. 1990; 258: 973-99.
30. Hirvonen T, Pietinen P, Virtanen M, Albanes D, Virtamo J,. Nutrient intake and use of beverages and the risk of kidney stones among male smokers. Am. J. Epidemiol. 1999; 150: 187-94. (Pubitemid 29340154)
31. Taylor EN, Stampfer MJ, Curhan GC,. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow-up. J. Am. Soc. Nephrol. 2004; 15: 3225-32. (Pubitemid 39578855)
32. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 1997; 336: 1117-24.
33. Waijers PM, Ocke MC, van Rossum CT, et al. Dietary patterns and survival in older Dutch women. Am. J. Clin. Nutr. 2006; 83: 1170-76. (Pubitemid 44713120)
34. Song Y, Manson JE, Buring JE, Liu S,. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 59-65. (Pubitemid 38196710)
35. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL,. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am. J. Physiol. 1995; 269: E745-52.
36. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A,. Magnesium. An update on physiological, clinical and analytical aspects. Clin. Chim. Acta 2000; 294: 1-26. (Pubitemid 30155803)
37. ABS. National Nutrition Survey, Foods Eaten, Australia. Australian Bureau of Statistics: Camberra, Cat No 4804.0. 1999 (McLennan W and Podger A).
38. Kuzniarz M, Mitchell P, Cumming RG, Flood VM,. Use of vitamin supplements and cataract: The Blue Mountains Eye Study. Am. J. Ophthalmol. 2000; 132: 19-26.
39. Kuan Y, Hossain M, Surman J, El Nahas AM, Haylor J,. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol. Dial. Transplant. 2005; 20: 2394-401. (Pubitemid 41548862)
40. NHMRC. Editor: Colin Binns. Dietary Guidelines for Older Australians. Commonwealth of Australia, 1999.
41. NHMRC and Dept Health and Ageing. Nutrient Reference Values for Australia and New Zealand. Commonwealth of Australia. 2006.